• CLS launched a rights issue of units of up to SEK 39.5 million, each unit including 3 warrants of series TO 9 B issued free.
• Rights: 1 unit right per share on July 31, 2026; 6 unit rights subscribe 1 unit priced at SEK 7.6.
• Issue covers up to 15,583,296 TO 9 B warrants; each warrant subscribes 1 new B-share at SEK 1.9.
• Warrant exercise window set for March 1–15, 2027; last trading day expected March 11, 2027.
• Full exercise could raise an additional SEK 29.6 million before transaction costs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CLS - Clinical Laserthermia Systems AB published the original content used to generate this news brief via Cision (Ref. ID: 20260723:BIT:1172:0) on July 23, 2026, and is solely responsible for the information contained therein.